April 19, 2018 | Story Review

Can ‘thinking differently’ help sooth chronic back pain? Hard to tell from HealthDay’s fuzzy reporting

The story doesn’t really explain the differences between the standard and experimental therapies in the small trial.

3 Star

Overcoming Fear of Back Pain May Spur Recovery

April 17, 2018 | Story Review

Immunotherapy prolongs survival, but at what cost? Washington Post needed more on treatment downsides

Most significantly, it doesn’t tell us about the $150,000 annual price tag for each patient.

3 Star

For advanced lung cancer, immune therapy plus chemo prolongs survival

April 17, 2018 | Story Review

Without any independent sources providing insight, readers of TIME’s coverage on lung cancer immunotherapy mostly left in the dark

When the stakes are this high, it’s critical that news stories give a clear picture of the proven benefits, limitations of the evidence, potential side effects, and costs.

2 Star

New Studies Show Immune Treatments Could Be Key in the Fight Against Lung Cancer

April 11, 2018 | Story Review

Diagnosing Alzheimer’s using biomarkers–AP makes it clear that there is no benefit to patients

Still, we would have liked to see comment from an independent source on how this news might be misconstrued, especially by readers worried about their own risk for developing the disease.

4 Star

New way of defining Alzheimer's aims to find disease sooner

April 11, 2018 | Story Review

By downplaying risks, NY Times column gives lopsided take on new shingles vaccine

A study shows that the severity of the side effects of the vaccine were much more intense than what the Times implies.

3 Star

Why You Should Get the New Shingles Vaccine

April 5, 2018 | Story Review

CNN leaves out key limitation of study on legalizing marijuana and opioid use

There was no way to know if anyone was actually choosing to use marijuana instead of opioids.

3 Star

Marijuana legalization could help offset opioid epidemic, studies find

April 5, 2018 | Story Review

Boston Globe overlooks evidence showing many patients not helped by ‘bionic’ joint replacements

This was amplified by the lack of specific data on benefits for patients, and the only expert quoted has a conflict of interest that wasn’t disclosed.

3 Star

Boomers are going bionic, and they want joint replacements to let them do it all

April 4, 2018 | Story Review 2

Prostate cancer gene test: WSJ skirts around lack of long-term data

To its credit, the story does discuss the rather expensive costs of the tests and quotes various sources.

3 Star

Prostate-Cancer Gene Test Helps Patients Decide on Treatment

March 29, 2018 | Story Review

AP story on ‘selfie medicine’ adherence programs overlooked evidence showing they don’t work well

However, it did wisely mention concerns about privacy and data security.

3 Star

Selfie medicine: Phone apps push people to take their pills

March 27, 2018 | Story Review

Reuters lets Roche make data-free claims about drug’s impact on lung cancer survival

To its credit, the story makes clear that Roche is going public with such incomplete and at best data-free pronouncements about incremental results in a “bid to catch up” to competitors’ better known immunotherapies.

2 Star

Roche's Tecentriq cocktail adds to lung cancer survival success

Toolkit

Tips for Understanding Studies

View More

Toolkit